Do analysts rate BHC or TLRY?

Tilray Brands has a consensus price target of C$13.30, suggesting a potential upside of 91.09%. Given Tilray Brands' higher possible upside, analysts clearly believe Tilray Brands is more favorable than Bausch Health Companies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch Health Companies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Tilray Brands 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts rate AUP or TLRY?

Tilray Brands has a consensus target price of C$13.30, suggesting a potential upside of 91.09%. Given Tilray Brands' stronger consensus rating and higher probable upside, analysts plainly believe Tilray Brands is more favorable than Aurinia Pharmaceuticals. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurinia Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Tilray Brands 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts rate TLRY or CARA?

Tilray Brands currently has a consensus target price of C$13.30, indicating a potential upside of 91.09%. Given Tilray Brands' stronger consensus rating and higher possible upside, analysts plainly believe Tilray Brands is more favorable than Cara Operations. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tilray Brands 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Cara Operations 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher earnings and valuation, TLRY or CARA?

Cara Operations has lower revenue, but higher earnings than Tilray Brands. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Tilray Brands C$858.28M 0.98 -C$183.24M -C$14.63 N/A Cara Operations N/A N/A N/A N/A N/A

Which has higher valuation & earnings, CRON or TLRY?

Cronos Group has higher earnings, but lower revenue than Tilray Brands. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cronos Group C$159.54M 8.81 -C$32.78M N/A N/A Tilray Brands C$858.28M 0.98 -C$183.24M -C$14.63 N/A

Tilray Brands (TLRY) Competitors

C$6.96 0.00 (0.00%)

As of 06/12/2026 04:00 PM Eastern

Compare

TLRY vs. BHC, AUP, SLS, CARA, and CRON

Should you buy Tilray Brands stock or one of its competitors? MarketBeat compares Tilray Brands with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Tilray Brands include Bausch Health Companies (BHC), Aurinia Pharmaceuticals (AUP), Solaris Resources (SLS), Cara Operations (CARA), and Cronos Group (CRON). These companies are all part of the "pharmaceutical products" industry.

How does Tilray Brands compare to Bausch Health Companies?

Bausch Health Companies (TSE:BHC) and Tilray Brands (TSE:TLRY) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, media sentiment, valuation, earnings, analyst recommendations, profitability and dividends.

Bausch Health Companies has higher revenue and earnings than Tilray Brands. Bausch Health Companies is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch Health Companies	C$10.53B	0.25	-C$125.65M	-C$3.24	N/A
Tilray Brands	C$858.28M	0.98	-C$183.24M	-C$14.63	N/A

Bausch Health Companies has a beta of 0.942978, suggesting that its share price is 6% less volatile than the broader market. Comparatively, Tilray Brands has a beta of 3.007995, suggesting that its share price is 201% more volatile than the broader market.

In the previous week, Tilray Brands had 2 more articles in the media than Bausch Health Companies. MarketBeat recorded 2 mentions for Tilray Brands and 0 mentions for Bausch Health Companies. Tilray Brands' average media sentiment score of 0.07 beat Bausch Health Companies' score of 0.00 indicating that Tilray Brands is being referred to more favorably in the news media.

Company	Overall Sentiment
Bausch Health Companies	Neutral
Tilray Brands	Neutral

11.0% of Bausch Health Companies shares are owned by institutional investors. Comparatively, 4.4% of Tilray Brands shares are owned by institutional investors. 11.3% of Bausch Health Companies shares are owned by insiders. Comparatively, 0.7% of Tilray Brands shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Bausch Health Companies has a net margin of -13.54% compared to Tilray Brands' net margin of -158.75%. Bausch Health Companies' return on equity of 120.43% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bausch Health Companies	-13.54%	120.43%	4.16%
Tilray Brands	-158.75%	-88.06%	-1.41%

Tilray Brands has a consensus price target of C$13.30, suggesting a potential upside of 91.09%. Given Tilray Brands' higher possible upside, analysts clearly believe Tilray Brands is more favorable than Bausch Health Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch Health Companies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Bausch Health Companies beats Tilray Brands on 8 of the 14 factors compared between the two stocks.

How does Tilray Brands compare to Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals (TSE:AUP) and Tilray Brands (TSE:TLRY) are both pharmaceutical products companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends, valuation and media sentiment.

Tilray Brands has higher revenue and earnings than Aurinia Pharmaceuticals. Tilray Brands is trading at a lower price-to-earnings ratio than Aurinia Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurinia Pharmaceuticals	C$57.59M	0.00	-C$190.03M	-C$1.48	N/A
Tilray Brands	C$858.28M	0.98	-C$183.24M	-C$14.63	N/A

In the previous week, Tilray Brands had 2 more articles in the media than Aurinia Pharmaceuticals. MarketBeat recorded 2 mentions for Tilray Brands and 0 mentions for Aurinia Pharmaceuticals. Tilray Brands' average media sentiment score of 0.07 beat Aurinia Pharmaceuticals' score of 0.00 indicating that Tilray Brands is being referred to more favorably in the news media.

Company	Overall Sentiment
Aurinia Pharmaceuticals	Neutral
Tilray Brands	Neutral

4.4% of Tilray Brands shares are owned by institutional investors. 0.7% of Tilray Brands shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Aurinia Pharmaceuticals has a net margin of 0.00% compared to Tilray Brands' net margin of -158.75%. Aurinia Pharmaceuticals' return on equity of 0.00% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurinia Pharmaceuticals	N/A	N/A	N/A
Tilray Brands	-158.75%	-88.06%	-1.41%

Tilray Brands has a consensus target price of C$13.30, suggesting a potential upside of 91.09%. Given Tilray Brands' stronger consensus rating and higher probable upside, analysts plainly believe Tilray Brands is more favorable than Aurinia Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurinia Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Tilray Brands beats Aurinia Pharmaceuticals on 9 of the 13 factors compared between the two stocks.

How does Tilray Brands compare to Solaris Resources?

Solaris Resources (TSE:SLS) and Tilray Brands (TSE:TLRY) are both pharmaceutical products companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, risk, profitability, dividends, earnings and media sentiment.

Solaris Resources has a net margin of 0.00% compared to Tilray Brands' net margin of -158.75%. Solaris Resources' return on equity of 60.97% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solaris Resources	N/A	60.97%	-51.67%
Tilray Brands	-158.75%	-88.06%	-1.41%

Solaris Resources currently has a consensus price target of C$19.50, suggesting a potential upside of 48.85%. Tilray Brands has a consensus price target of C$13.30, suggesting a potential upside of 91.09%. Given Tilray Brands' higher probable upside, analysts clearly believe Tilray Brands is more favorable than Solaris Resources.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solaris Resources	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Solaris Resources has higher earnings, but lower revenue than Tilray Brands. Solaris Resources is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solaris Resources	N/A	N/A	-C$46.49M	-C$0.19	N/A
Tilray Brands	C$858.28M	0.98	-C$183.24M	-C$14.63	N/A

16.5% of Solaris Resources shares are owned by institutional investors. Comparatively, 4.4% of Tilray Brands shares are owned by institutional investors. 40.6% of Solaris Resources shares are owned by insiders. Comparatively, 0.7% of Tilray Brands shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Solaris Resources has a beta of 1.721408, indicating that its stock price is 72% more volatile than the broader market. Comparatively, Tilray Brands has a beta of 3.007995, indicating that its stock price is 201% more volatile than the broader market.

In the previous week, Tilray Brands had 2 more articles in the media than Solaris Resources. MarketBeat recorded 2 mentions for Tilray Brands and 0 mentions for Solaris Resources. Tilray Brands' average media sentiment score of 0.07 beat Solaris Resources' score of 0.00 indicating that Tilray Brands is being referred to more favorably in the news media.

Company	Overall Sentiment
Solaris Resources	Neutral
Tilray Brands	Neutral

Summary

Solaris Resources beats Tilray Brands on 8 of the 15 factors compared between the two stocks.

How does Tilray Brands compare to Cara Operations?

Tilray Brands (TSE:TLRY) and Cara Operations (TSE:CARA) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, media sentiment, analyst recommendations, risk, profitability and earnings.

Tilray Brands currently has a consensus target price of C$13.30, indicating a potential upside of 91.09%. Given Tilray Brands' stronger consensus rating and higher possible upside, analysts plainly believe Tilray Brands is more favorable than Cara Operations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Cara Operations	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Cara Operations has lower revenue, but higher earnings than Tilray Brands.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	C$858.28M	0.98	-C$183.24M	-C$14.63	N/A
Cara Operations	N/A	N/A	N/A	N/A	N/A

Cara Operations has a net margin of 0.00% compared to Tilray Brands' net margin of -158.75%. Cara Operations' return on equity of 0.00% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-158.75%	-88.06%	-1.41%
Cara Operations	N/A	N/A	N/A

In the previous week, Tilray Brands had 2 more articles in the media than Cara Operations. MarketBeat recorded 2 mentions for Tilray Brands and 0 mentions for Cara Operations. Tilray Brands' average media sentiment score of 0.07 beat Cara Operations' score of 0.00 indicating that Tilray Brands is being referred to more favorably in the media.

Company	Overall Sentiment
Tilray Brands	Neutral
Cara Operations	Neutral

4.4% of Tilray Brands shares are owned by institutional investors. 0.7% of Tilray Brands shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Tilray Brands beats Cara Operations on 7 of the 10 factors compared between the two stocks.

How does Tilray Brands compare to Cronos Group?

Cronos Group (TSE:CRON) and Tilray Brands (TSE:TLRY) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, media sentiment, risk, profitability and institutional ownership.

In the previous week, Tilray Brands had 2 more articles in the media than Cronos Group. MarketBeat recorded 2 mentions for Tilray Brands and 0 mentions for Cronos Group. Tilray Brands' average media sentiment score of 0.07 beat Cronos Group's score of 0.00 indicating that Tilray Brands is being referred to more favorably in the news media.

Company	Overall Sentiment
Cronos Group	Neutral
Tilray Brands	Neutral

Cronos Group has higher earnings, but lower revenue than Tilray Brands.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	C$159.54M	8.81	-C$32.78M	N/A	N/A
Tilray Brands	C$858.28M	0.98	-C$183.24M	-C$14.63	N/A

Cronos Group currently has a consensus price target of C$4.75, indicating a potential upside of 26.33%. Tilray Brands has a consensus price target of C$13.30, indicating a potential upside of 91.09%. Given Tilray Brands' higher probable upside, analysts clearly believe Tilray Brands is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Cronos Group has a beta of 1.134248, indicating that its stock price is 13% more volatile than the broader market. Comparatively, Tilray Brands has a beta of 3.007995, indicating that its stock price is 201% more volatile than the broader market.

Cronos Group has a net margin of -1.29% compared to Tilray Brands' net margin of -158.75%. Cronos Group's return on equity of -0.19% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	-1.29%	-0.19%	-3.73%
Tilray Brands	-158.75%	-88.06%	-1.41%

4.6% of Cronos Group shares are owned by institutional investors. Comparatively, 4.4% of Tilray Brands shares are owned by institutional investors. 46.4% of Cronos Group shares are owned by company insiders. Comparatively, 0.7% of Tilray Brands shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Cronos Group beats Tilray Brands on 8 of the 15 factors compared between the two stocks.

Get Tilray Brands News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TLRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TLRY vs. The Competition

Export

Metric	Tilray Brands	Drug Manufacturers Industry	Medical Sector	TSE Exchange
Market Cap	C$840.89M	C$7.16B	C$6.74B	C$13.03B
Dividend Yield	N/A	2.94%	2.67%	6.19%
P/E Ratio	-0.48	5.01	24.21	36.94
Price / Sales	0.98	1,641.46	512.04	10.45
Price / Cash	5.95	10.18	27.48	82.29
Price / Book	0.51	10.44	10.66	4.47
Net Income	-C$183.24M	C$20.27B	C$3.57B	C$299.09M
7 Day Performance	-0.57%	-0.85%	0.58%	0.65%
1 Month Performance	-4.40%	6.93%	1.54%	-0.08%
1 Year Performance	24.29%	15.90%	25.40%	41.90%

Tilray Brands Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TLRY Tilray Brands	1.3647 of 5 stars	C$6.96 flat	C$13.30 +91.1%	+24.3%	C$840.89M	C$858.28M	N/A	2,650	Gap Up
BHC Bausch Health Companies	0.3508 of 5 stars	C$7.18 -0.6%	N/A	-12.7%	C$2.68B	C$10.53B	N/A	19,900
AUP Aurinia Pharmaceuticals	N/A	N/A	N/A	N/A	C$2.15B	C$57.59M	N/A	300	High Trading Volume
SLS Solaris Resources	1.477 of 5 stars	C$11.69 -0.6%	C$19.50 +66.8%	+108.6%	C$1.95B	N/A	N/A	10
CARA Cara Operations	N/A	N/A	N/A	N/A	C$1.62B	N/A	N/A	80

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:TLRY) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Tilray Brands (TLRY) Competitors

TLRY vs. BHC, AUP, SLS, CARA, and CRON

How does Tilray Brands compare to Bausch Health Companies?

Summary

How does Tilray Brands compare to Aurinia Pharmaceuticals?

Summary

How does Tilray Brands compare to Solaris Resources?

Summary

How does Tilray Brands compare to Cara Operations?

Summary

How does Tilray Brands compare to Cronos Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TLRY vs. The Competition

Tilray Brands Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Tilray Brands (TLRY) Competitors

TLRY vs. BHC, AUP, SLS, CARA, and CRON

How does Tilray Brands compare to Bausch Health Companies?

Which has preferable valuation and earnings, BHC or TLRY?

Which has more risk & volatility, BHC or TLRY?

Does the media prefer BHC or TLRY?

Do insiders and institutionals hold more shares of BHC or TLRY?

Is BHC or TLRY more profitable?

Do analysts rate BHC or TLRY?

Summary

How does Tilray Brands compare to Aurinia Pharmaceuticals?

Which has stronger earnings & valuation, AUP or TLRY?

Does the media refer more to AUP or TLRY?

Do insiders & institutionals hold more shares of AUP or TLRY?

Is AUP or TLRY more profitable?

Do analysts rate AUP or TLRY?

Summary

How does Tilray Brands compare to Solaris Resources?

Is SLS or TLRY more profitable?

Do analysts prefer SLS or TLRY?

Which has preferable valuation & earnings, SLS or TLRY?

Do institutionals and insiders hold more shares of SLS or TLRY?

Which has more volatility and risk, SLS or TLRY?

Does the media prefer SLS or TLRY?

Summary

How does Tilray Brands compare to Cara Operations?

Do analysts rate TLRY or CARA?

Which has higher earnings and valuation, TLRY or CARA?

Is TLRY or CARA more profitable?

Does the media refer more to TLRY or CARA?

Do institutionals & insiders believe in TLRY or CARA?

Summary

How does Tilray Brands compare to Cronos Group?

Does the media prefer CRON or TLRY?

Which has higher valuation & earnings, CRON or TLRY?

Do analysts prefer CRON or TLRY?

Which has more risk and volatility, CRON or TLRY?

Is CRON or TLRY more profitable?

Do institutionals & insiders hold more shares of CRON or TLRY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TLRY vs. The Competition

Tilray Brands Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools